Partial Thromboplastin Time Concept

subject area of

• A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of Canada  Journal Articles
• A cohort study of coagulation parameters and the use of blood products in surgery of the thoracic and thoracoabdominal aorta  Journal Articles
• A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation  Journal Articles
• A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury  Journal Articles
• A novel congenital haemostatic defect  Journal Articles
• A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin  Journal Articles
• A standard heparin nomogram for the management of heparin therapy  Journal Articles
• ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?  Journal Articles
• Abelacimab for Prevention of Venous Thromboembolism  Journal Articles
• Acquired Hemophilia A  Journal Articles
• Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction  Journal Articles
• Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparin  Journal Articles
• Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis  Journal Articles
• Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis  Journal Articles
• Age-related differences in heparin response  Journal Articles
• An Approach to Assigning In Vitro Potency to Unfractionated and Low Molecular Weight Heparins Based on the Inhibition of Prothrombin Activation and Catalysis of Thrombin Inhibition  Journal Articles
• An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice  Conferences
• Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls  Journal Articles
• Anticoagulant response after dalteparin overdose  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic therapy in deep vein thrombosis and pulmonary embolism  Journal Articles
• Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.  Journal Articles
• Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices  Journal Articles
• Autoimmune heparin‐induced thrombocytopenia  Journal Articles
• Autoimmune heparin‐induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin  Journal Articles
• Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time  Journal Articles
• Coagulation Assays  Journal Articles
• Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure  Journal Articles
• Coagulopathy in a patient with nephrotic syndrome  Journal Articles
• Coagulopathy related to dilution and hypotension during massive transfusion  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism  Journal Articles
• Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction  Journal Articles
• Comparison of the Effects of Two Doses of Recombinant Hirudin Compared With Heparin in Patients With Acute Myocardial Ischemia Without ST Elevation  Journal Articles
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Journal Articles
• Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents  Journal Articles
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Journal Articles
• Complications of long‐term anticoagulation  Journal Articles
• Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis  Journal Articles
• Critical Values in the Coagulation Laboratory Results of a Survey of the North American Specialized Coagulation Laboratory Association  Journal Articles
• DOACs: role of anti-Xa and drug level monitoring.  Journal Articles
• Dabigatran monitoring made simple?  Journal Articles
• Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential  Journal Articles
• Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis  Journal Articles
• Development of the human coagulation system in the full-term infant  Journal Articles
• Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation  Journal Articles
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Journal Articles
• Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction  Journal Articles
• Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents  Journal Articles
• Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin  Journal Articles
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Journal Articles
• Effects on Thrombin Generation of Single Injections of Hirulog™ in Patients with Calf Vein Thrombosis  Journal Articles
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Journal Articles
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Journal Articles
• Establishing a Therapeutic Range for Heparin Therapy  Journal Articles
• Evidence for a saturable mechanism of disappearance of standard heparin in rabbits  Journal Articles
• Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis  Journal Articles
• Factors XI and XII are low in subjects with liver disease  Journal Articles
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists  Journal Articles
• Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.  Journal Articles
• Further Studies on the Mechanisms for the Antithrombotic Effects of Sulfated Polysaccharides in Rabbits  Journal Articles
• HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions  Journal Articles
• Hemorrhagic Complications of Anticoagulant Therapy  Journal Articles
• Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance  Journal Articles
• Heparin and Low-Molecular-Weight Heparin  Journal Articles
• Heparin resistance in acute coronary syndromes  Journal Articles
• Heparin-Induced Thrombocytopenia in Critically Ill Patients  Journal Articles
• Heparin‐induced thrombocytopenia: pathogenesis and management  Journal Articles
• High prevalence of abnormal preoperative coagulation tests in patients with adolescent idiopathic scoliosis  Journal Articles
• Hirudin causes more bleeding than heparin in a rabbit ear bleeding model  Journal Articles
• How to use unfractionated heparin to treat neonatal thrombosis in clinical practice  Journal Articles
• Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase  Journal Articles
• In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation  Journal Articles
• Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082  Journal Articles
• Initial treatment of venous thromboembolism  Journal Articles
• International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Journal Articles
• Laboratory Investigations for Bleeding Disorders  Journal Articles
• Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants  Journal Articles
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Journal Articles
• Management of iliofemoral thrombosis in a pregnant patient with heparin resistance  Journal Articles
• Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin Therapy  Journal Articles
• Mechanism of Action and Monitoring of Anticoagulants  Journal Articles
• Monitoring Heparin Therapy  Journal Articles
• Monitoring unfractionated heparin with the aPTT: Time for a fresh look  Journal Articles
• Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor  Journal Articles
• NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank  Journal Articles
• Non-biological factors in day to day variation of heparin requirements.  Journal Articles
• Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis  Journal Articles
• Optimal therapeutic level of heparin therapy in patients with venous thrombosis  Journal Articles
• Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation  Journal Articles
• Pharmacological Actions of Sulodexide  Journal Articles
• Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography  Journal Articles
• Prevention of left ventricular mural thrombus  Journal Articles
• Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding  Journal Articles
• Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial  Journal Articles
• Recurrent Venous Thrombosis and Heparin Therapy  Journal Articles
• Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin  Journal Articles
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Journal Articles
• Repeated oral administration of chitosan/DNA nanoparticles delivers functional FVIII with the absence of antibodies in hemophilia A mice  Journal Articles
• Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides  Journal Articles
• Reversal of direct oral anticoagulants: a practical approach  Journal Articles
• Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin  Journal Articles
• Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis  Journal Articles
• Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin  Journal Articles
• Sustained expression of coagulation factor IX by modified cord blood‐derived mesenchymal stromal cells  Journal Articles
• The APTT Response of Pregnant Plasma to Unfractionated Heparin  Journal Articles
• The Effect of Thrombin Inhibitors on Tissue Plasminogen Activator Induced Thrombolysis in a Rat Model  Journal Articles
• The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study  Journal Articles
• The absence of `minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios  Journal Articles
• The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig  Journal Articles
• The disappearance of a low molecular weight heparin fraction (cy 216) differs from standard heparin in rabbits  Journal Articles
• The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface  Other
• The factor VIII-independent activation of factor X by factors IXa and VII in plasma  Journal Articles
• The incidence and impact of lupus anticoagulants among patients in the intensive care unit.  Journal Articles
• The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor  Journal Articles
• The multiple faces of the partial thromboplastin time APTT  Journal Articles
• The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release  Journal Articles
• The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin  Journal Articles
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits  Journal Articles
• Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin  Journal Articles
• Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes  Journal Articles
• Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.  Journal Articles
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Journal Articles
• Use of a Fixed Activated Partial Thromboplastin Time Ratio to Establish a Therapeutic Range for Unfractionated Heparin  Journal Articles
• Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I  Journal Articles
• Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.  Journal Articles
• Utility of aPTT in monitoring unfractionated heparin in children  Journal Articles
• α2-Macroglobulin Remains as Important as Antithrombin III for Thrombin Regulation in Cord Plasma in the Presence of Endothelial Cell Surfaces  Journal Articles